Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor of the meta-disulfamoylbenzene class.
Medscape - Periodic paralysis indication dosing for Keveyis (dichlorphenamide), frequency-based adverse effects, comprehensive interactions, ...
Physician reviewed dichlorphenamide patient information - includes dichlorphenamide description, dosage and directions.
Dichlorphenamide is a carbonic anhydrase inhibitor. Carbonic anhydrase is a protein in your body. Dichlorphenamide reduces the activity of this protein.
KEVEYIS® (dichlorphenamide) is the only FDA-approved treatment for hyperkalemic and hypokalemic Primary Periodic Paralysis.
Dichlorphenamide is only found in individuals that have used or taken this drug. It is a carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
Learn about Keveyis (Dichlorphenamide Tablets) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related ...
Dichlorphenamide is used to treat inherited muscle disorders, such as primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and ...
Jun 13, 2005 ... Dichlorphenamide is an oral carbonic anhydrase inhibitor indicated for adjunctive treatment of: chronic simple (open-angle) glaucoma, ...